Wave Pharmaceuticals Limited - Company Profile

It is a pharma public limited company based in Delhi, Delhi, India, established in 1997.
1997 Delhi, Delhi, India Active
Last Updated:
Access Report
About Wave Pharmaceuticals Limited

Wave Pharmaceuticals Limited, a active public limited company, was established on 08 August 1997 in Delhi, Delhi, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24231DL1997PLC088998. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹4.95 Cr.

It upholds a compliant status. Its leadership includes Nikhil Gupta (Director), Sanjay Gupta (Director), Sarita Gupta (Director). Past directors included Vijay Kumar Matta, Nikhil Gupta, Neelu Matta. It holds no open charges and ₹5.07 M settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at B-6, Oberoi Appartments, 2 Sham Nath Marg, Civil Lines, Delhi, Delhi, 110054.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24231DL1997PLC088998

  • Registration Number

    088998

  • Incorporation Date

    08 August 1997

  • Authorized Capital

    ₹5.00 Cr

  • Paid-Up Capital

    ₹4.95 Cr

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 5.00 Cr
  • Paid Up Capital ₹ 4.95 Cr
  • Company Age 28 Year, 6 Months
  • Last Filing with ROC 31 Mar 2025
  • Satisfied Charges ₹ 5.07 M
  • Revenue Growth **** 49.70%
  • Profit Growth **** -2.13%
  • Ebitda **** -431.57%
  • Net Worth 6.29%
  • Total Assets **** 59.21%
Company report

Wave Pharmaceuticals Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Wave Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Wave Pharmaceuticals Limited?
Current Directors
Name Designation Appointment Date Status
Nikhil Gupta Director 28 Jan 2017 Current
Sanjay Gupta Director 28 Jan 2017 Current
Sarita Gupta Director 10 Feb 2018 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 10 Feb 2018 Past
Pramod Abcsdd Additional Director 29 Sep 2018 Past
Pramod Abcsdd Director 01 Feb 2017 Past
Pramod Abcsdd Director 10 Feb 2018 Past
Pramod Abcsdd Additional Director 29 Sep 2018 Past
Pramod Abcsdd Director 01 Feb 2017 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Wave Pharmaceuticals.

Wave Pharmaceuticals Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 49.7% increase. The company also saw a slight decrease in profitability, with a 2.13% decrease in profit. The company's net worth moved up by a moderate rise of 6.29%.

Wave Pharmaceuticals revenue growth over time
Wave Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 49.70%
*******
*******
*******
*******
Revenue from Operations
*******
 54.16%
*******
*******
*******
*******
Total Assets
*******
 59.21%
*******
*******
*******
*******
Profit or Loss
*******
 -2.13%
*******
*******
*******
*******
Net Worth
*******
 6.29%
*******
*******
*******
*******
EBITDA
*******
 -431.57%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Wave Pharmaceuticals?

In 2023, Wave Pharmaceuticals had a promoter holding of 95.70% and a public holding of 4.31%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹0

Satisfied Charges

₹5,065,000.00

Charges Breakdown by Lending Institutions
  • Punjab National Bank : 0.26 Cr
  • Canara Bank : 0.25 Cr
Latest Charge Details
Date Lender Amount Status
07 Mar 2003 Canara Bank ₹2.50 M Satisfied
12 Dec 2001 Punjab National Bank ₹2.57 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Wave Pharmaceuticals?

Unlock and access historical data on people associated with Wave Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Wave Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Wave Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Wave Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Wave Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    Wave Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was recorded as a recent event.

  • Director Appointment

    The activity Sarita Gupta was appointed as a Director was appointed as a Director on 10 Feb 2018 & has been associated with this company since 8 years 21 days . was completed.

  • Charges

    The activity A charge registered on 07 Mar 2003 via Charge ID 90037931 with Canara Bank was fully satisfied on 30 Aug 2017. was completed.

  • Charges

    The activity A charge registered on 12 Dec 2001 via Charge ID 90036942 with Punjab National Bank was fully satisfied on 29 Aug 2017. was completed.

  • Director Appointment

    Progress on Nikhil Gupta was appointed as a Director was appointed as a Director on 28 Jan 2017 & has been associated with this company since 9 years 1 month . was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Wave Pharmaceuticals Limited?

The CIN of Wave Pharmaceuticals Limited is U24231DL1997PLC088998.

Where is Wave Pharmaceuticals Limited headquartered?

Wave Pharmaceuticals Limited is headquartered at B-6, Oberoi Appartments, 2 Sham Nath Marg, Civil Lines, Delhi, Delhi, 110054.

When was Wave Pharmaceuticals Limited incorporated?

Wave Pharmaceuticals Limited was incorporated on 08 August 1997.

Who are the current directors of Wave Pharmaceuticals Limited?

The current directors of Wave Pharmaceuticals Limited are

What is the primary industry of Wave Pharmaceuticals Limited?

The primary industry of Wave Pharmaceuticals Limited is Manufacturing.

Is Wave Pharmaceuticals Limited a listed company?

Wave Pharmaceuticals Limited is unlisted.

What is the capital structure of Wave Pharmaceuticals Limited?

The authorized capital of Wave Pharmaceuticals Limited is ₹5.00 Cr, and the paid-up capital is ₹4.95 Cr.

What is the compliance status of Wave Pharmaceuticals Limited?

The compliance status of Wave Pharmaceuticals Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available